Word

EG 427 PINPOINT GENE THERAPY

Status

Registered

Status Code

700

Status Date

Tuesday, December 27, 2022

Serial Number

90792354

Registration Number

6933394

Registration Date

Tuesday, December 27, 2022

Mark Type

3000

Filing Date

Thursday, June 24, 2021

Published for Opposition

Tuesday, October 11, 2022

Trademark Owner History

EG427 - Original Registrant
GENELPIS - Original Applicant

Classifications

5 Pharmaceutical preparations for use as treatments of neurological pathologies; biological tissue cultures for medical purposes; albuminous preparations for medical purposes; chemical preparations for use as treatments of neurological pathologies; Chemical and biological reagents for medical, pharmaceutical or veterinary purposes; reagents and culture media for in vitro medical, pharmaceutical or veterinary diagnosis; Pharmaceutical preparations for human use for the treatment of neurological pathologies; Bacterial, bacteriological, biological and chemical preparations for medical and therapeutic purposes, namely, for treatment of neurological pathologies

1 Chemical and biochemical preparations for scientific and research purposes; reagents for scientific and research purposes; chemical preparations and chemical reagents for industrial, agri-food, cosmetic, pharmaceutical and environmental purposes, other than for medical or veterinary use; Stem cells for research purposes; Bacterial, bacteriological, biological and chemical preparations for scientific purposes other than for medical or veterinary use

10 Surgical apparatus and instruments for medical or veterinary use; therapeutic and assistive devices to diagnose or administer treatments for cardiovascular, digestive, endocrine, genitourinary, genetic, hematological, immune, infectious, neurological, oncologic, respiratory, sight, hearing, pulmonary and skin diseases, designed for people with disabilities; In vitro diagnostic apparatus and instruments for medical, pharmaceutical or veterinary use in the field of gene therapy for diagnosis of cardiovascular, digestive, endocrine, genitourinary, genetic, hematological, immune, infectious, neurological, oncologic, respiratory, and skin diseases

The mark consists of the terms "EG 427" formed from a series of dots above the stylized words "PINPOINT GENE THERAPY".
EG FOUR TWO SEVEN PINPOINT GENE THERAPY; EG FOUR HUNDRED TWENTY SEVEN PINPOINT GENE THERAPY
"GENE THERAPY"

Trademark Events

Dec 27, 2022

Notice Of Registration Confirmation Emailed

Dec 27, 2022

Registered-Principal Register

Oct 11, 2022

Official Gazette Publication Confirmation E-Mailed

Oct 11, 2022

Published For Opposition

Sep 21, 2022

Notification Of Notice Of Publication E-Mailed

Sep 7, 2022

Electronic Record Review Complete

Sep 2, 2022

On Hold - Electronic Record Review Required

Aug 26, 2022

Approved For Pub - Principal Register

Aug 23, 2022

Teas/Email Correspondence Entered

Aug 22, 2022

Correspondence Received In Law Office

Aug 22, 2022

Teas Response To Office Action Received

Mar 25, 2022

Notification Of Non-Final Action E-Mailed

Mar 25, 2022

Non-Final Action E-Mailed

Mar 25, 2022

Non-Final Action Written

Mar 16, 2022

Assigned To Examiner

Feb 4, 2022

Automatic Update Of Assignment Of Ownership

Sep 9, 2021

Notice Of Design Search Code E-Mailed

Sep 8, 2021

New Application Office Supplied Data Entered In Tram

Jun 28, 2021

New Application Entered In Tram